Anti-fibrotic agents target various stages of the fibrotic process. Some common mechanisms include:
- Inhibition of fibroblast activation and differentiation. - Reduction of ECM production. - Enhanced ECM degradation. - Modulation of inflammatory responses. - Interference with signaling pathways like TGF-β and other fibrogenic cytokines.
